PMID- 28634644 OWN - NLM STAT- MEDLINE DCOM- 20181105 LR - 20191210 IS - 1573-6709 (Electronic) IS - 0033-2720 (Linking) VI - 89 IP - 1 DP - 2018 Mar TI - Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder. PG - 141-155 LID - 10.1007/s11126-017-9522-y [doi] AB - This study sought to determine the minimal clinically important difference (MCID) for two frequently used measures of symptom severity in Post-Traumatic Stress Disorder: the Clinician Administered PTSD Scale (CAPS) and the PTSD Symptom Checklist (PCL). Data from a randomized clinical trial of antipsychotic medication in military-related treatment-resistant PTSD (N= 267) included assessments 4 times over 26 weeks. Methods for estimating the MCID were based on both the anchor-based approach, using the Clinical Global Impressions (CGI) severity and improvement scales, rated by both clinicians and patients; and the distribution-based approach (based on standardized z-scores). Severity and change scores on the CAPS and PCL were converted to z-scores and compared across CGI levels using analysis of variance. The average difference in CAPS z-scores between each of three CGI levels between "moderate" to "severe" and from "no change" to "much improved" was 0.758 for clinician CGI ratings and 0.525 for patient CGI ratings and were similar for the PCL (0.483 and 0.471) with all differences significant at p<.0001). Clinically meaningful CAPS and PCL severity and change z-scores range between 0.5-0.8 standard deviations. The MCID estimates suggested here provide an empirical basis for determining whether statistically significant changes in CAPS and PCL scores are clinically meaningful. FAU - Stefanovics, Elina A AU - Stefanovics EA AD - VA New England Mental Illness Research and Education Center, VA Connecticut Healthcare System (116A-4), 950 Campbell Avenue, Building 36, West Haven, CT, 06516, USA. elina.stefanovics@yale.edu. AD - Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. elina.stefanovics@yale.edu. FAU - Rosenheck, Robert A AU - Rosenheck RA AD - VA New England Mental Illness Research and Education Center, VA Connecticut Healthcare System (116A-4), 950 Campbell Avenue, Building 36, West Haven, CT, 06516, USA. AD - Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. FAU - Jones, Karen M AU - Jones KM AD - VA Cooperative Studies Coordinating Center, Point, Perry, MD, USA. FAU - Huang, Grant AU - Huang G AD - VA Cooperative Studies Program Central Office, Washington, D.C, USA. FAU - Krystal, John H AU - Krystal JH AD - VA New England Mental Illness Research and Education Center, VA Connecticut Healthcare System (116A-4), 950 Campbell Avenue, Building 36, West Haven, CT, 06516, USA. AD - Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. AD - Clinical Neuroscience Division, Department of Veterans Affairs National Center for PTSD, West Haven, CT, USA. LA - eng PT - Journal Article PT - Randomized Controlled Trial PL - United States TA - Psychiatr Q JT - The Psychiatric quarterly JID - 0376465 RN - 0 (Antipsychotic Agents) SB - IM MH - Adult MH - Antipsychotic Agents/*pharmacology MH - Female MH - Humans MH - Male MH - Middle Aged MH - *Minimal Clinically Important Difference MH - Outcome Assessment, Health Care/methods/*standards MH - Psychiatric Status Rating Scales/*standards MH - Stress Disorders, Post-Traumatic/*drug therapy/*physiopathology MH - United States MH - United States Department of Veterans Affairs MH - *Veterans OTO - NOTNLM OT - Minimal clinically important difference OT - Outcome assessment OT - PTSD EDAT- 2017/06/22 06:00 MHDA- 2018/11/06 06:00 CRDT- 2017/06/22 06:00 PHST- 2017/06/22 06:00 [pubmed] PHST- 2018/11/06 06:00 [medline] PHST- 2017/06/22 06:00 [entrez] AID - 10.1007/s11126-017-9522-y [pii] AID - 10.1007/s11126-017-9522-y [doi] PST - ppublish SO - Psychiatr Q. 2018 Mar;89(1):141-155. doi: 10.1007/s11126-017-9522-y.